Life Science REIT PLC
Life Science REIT plc is a specialist property business focused on the UK's growing life science sector. The Company's portfolio of assets is located across the Golden Triangle of research and development hubs in Oxford, Cambridge and London's Knowledge Quarter. Life Science REIT trades on the Main Market of the London Stock Exchange under the ticker LABS.
Life Science REIT PLC (LABS) - Total Liabilities
Latest total liabilities as of June 2025: GBX141.89 Million GBX
Based on the latest financial reports, Life Science REIT PLC (LABS) has total liabilities worth GBX141.89 Million GBX as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Life Science REIT PLC - Total Liabilities Trend (2021–2024)
This chart illustrates how Life Science REIT PLC's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Life Science REIT PLC Competitors by Total Liabilities
The table below lists competitors of Life Science REIT PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
MBH Mortgage Bank Co Plc
STU:FH21
|
Germany | €673.59 Billion |
|
Inspired Plc
LSE:INSE
|
UK | GBX94.73 Million |
|
Spielvgg Unterhaching KGAA
STU:S6P
|
Germany | €11.72 Million |
|
HALFORDS GROUP
MU:HDK
|
Germany | €725.70 Million |
|
INNOFACTOR (TJG.SG)
STU:TJG
|
Germany | €26.80 Million |
|
CARPHONE WARE GRP - Dusseldorf Stock Exchang
DU:CWB
|
Germany | €3.24 Billion |
Liability Composition Analysis (2021–2024)
This chart breaks down Life Science REIT PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.61 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Life Science REIT PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Life Science REIT PLC (2021–2024)
The table below shows the annual total liabilities of Life Science REIT PLC from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | GBX138.42 Million | +9.03% |
| 2023-12-31 | GBX126.96 Million | -1.10% |
| 2022-12-31 | GBX128.37 Million | +1086.45% |
| 2021-12-31 | GBX10.82 Million | -- |